Search research articles
Contact Us
Filters
Showing results (1-10 of 361) with videos related to
Page
of 37
Sort By:
Cancer Cell
|
September 13, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2014
Can targeting the androgen receptor in localized prostate cancer provide insights into why men with metastatic castration-resistant prostate cancer die?
Eric J Small
Cancer Cell
|
July 12, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2004
Monoclonal antibody therapy for prostate cancer: finally a reality?
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2008
Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment
Lawrence Fong, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2010
Developing immunotherapy as legitimate therapy for patients with prostate cancer
Eric J Small, Lawrence Fong
Expert Review of Anticancer Therapy
|
May 24, 2017
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment
Archana Anantharaman, Eric J Small
Current Oncology Reports
|
April 14, 2007
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Seminars in Oncology
|
October 23, 2003
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Page
of 37
Search research articles
Search
Showing results (1-10 of 361) with videos related to
Sort By:
Page
of 37
Cancer Cell
|
September 13, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2014
Can targeting the androgen receptor in localized prostate cancer provide insights into why men with metastatic castration-resistant prostate cancer die?
Eric J Small
Cancer Cell
|
July 12, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE Studies
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2023
Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2004
Monoclonal antibody therapy for prostate cancer: finally a reality?
Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2008
Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment
Lawrence Fong, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2010
Developing immunotherapy as legitimate therapy for patients with prostate cancer
Eric J Small, Lawrence Fong
Expert Review of Anticancer Therapy
|
May 24, 2017
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment
Archana Anantharaman, Eric J Small
Current Oncology Reports
|
April 14, 2007
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Seminars in Oncology
|
October 23, 2003
Immunotherapy for prostate cancer
Lawrence Fong, Eric J Small
Page
of 37